I am in my 75^th year, a bellwether of the Baby Boom generation, and I am looking forward to getting my Covid-19 vaccinations as soon as possible.

I am also a retired priest. Most of my ordained colleagues are younger than I and are serving active congregations.

So who goes first?

The Centers for Disease Control is apparently drawing up priority guidelines as to “essential” recipients, and it is thought that the elderly and “first responders” will go to the head of the line. I have heard no mention of clergy being on the list of essential workers.

It is, I suppose, not surprising that in a secular society, clergy are considered non-essential, but what surprises me is that there has been no call from church leaders in this matter. All too frequently there has been a sheepish plea for compliance with regulations restricting worship, even when secular bodies are exempted from them. The Supreme Court just struck down such a provision in New York as a violation of the free practice of religion, which is good, but such a decision lacks the rationale that religion – and Christianity in particular – is a matter of the life of the immortal soul, not just the body.

Read it all.

Few organisations have taken a bigger hit from the coronavirus pandemic than the Serbian Orthodox Church.

Over the past two months, Covid-19 has deprived the religious institution of its top leadership in both Serbia and Montenegro. But critics say the blows are self-inflicted, with traditional acts of worship the likely cause of infection.

The chain of events is extraordinary:

Last month, the Church’s senior bishop in Montenegro, Metropolitan Amfilohije, died after contracting coronavirus
Then, the Church’s leader, Patriarch Irinej, tested positive for Covid-19 days after presiding at his colleague’s funeral, and died
Last week, Bishop David of Krusevac, who conducted part of the service marking the Patriarch’s death, confirmed that he had contracted coronavirus for the second time
Amfilohije’s successor in Montenegro, Bishop Joanikije, has been unable to take up his duties due to his own struggle with the disease
Regardless of the decimation of its leadership, the Orthodox Church remains central to many people’s lives. And while schools in Serbia have mostly moved online because of the epidemic, communion is still performed in person, often in breach of the ban on gatherings of more than five people.

Read it all.

The church hierarchy being battered by Coronavirus https://t.co/TLyRSYgYX1

— Gerrarrdus (@Gerrarrdus) November 29, 2020

Continuing the spate of stunning news about COVID-19 vaccines, the biotech company Moderna announced the final results of the 30,000-person efficacy trial for its candidate in a press release today: Only 11 people who received two doses of the vaccine developed COVID-19 symptoms after being infected with the pandemic coronavirus, versus 185 symptomatic cases in a placebo group. That is an efficacy of 94.1%, the company says, far above what many vaccine scientists were expecting just a few weeks ago.

More impressive still, Moderna’s candidate had 100% efficacy against severe disease. There were zero such COVID-19 cases among those vaccinated, but 30 in the placebo group. The company today plans to file a request for emergency use authorization (EUA) for its vaccine with the U.S. Food and Drug Administration (FDA), and is also seeking a similar green light from the European Medicines Agency.

Read it all.

'Absolutely remarkable' : No one who got Moderna's vaccine in trial developed severe COVID-19 | Science | AAAS https://t.co/Hrtfy4XmWW

— Carl Zimmer (@carlzimmer) November 30, 2020

Further calls for prisoners to be prioritised for coronavirus jabs have come from the American Medical Association and a team of Oxford University researchers led by Professor Seena Fazel.

Ann Norman, who represents thousands of prison healthcare staff as the Royal College of Nursing’s professional lead for criminal justice, said: “I think there’s some lobbying there to do, but absolutely I believe prisoners are some of the most vulnerable people, and as such should be made a priority.”

Deborah Coles, Director of the charity INQUEST, said: “Clearly on both public health and human rights grounds, people in all detention settings must have high priority in receiving the vaccine.”

The Rt Rev James Langstaff, the Bishop of Rochester, said: “I would hope that Government would be sensible enough when [the vaccine] comes on stream to make sure it’s used in prisons sooner rather than later.”

Andrew Neilson, Director of Campaigns at the Howard League for Penal Reform, said: “In principle, prison staff and prisoners should be towards the front of the queue, given the risk that prisons pose as epidemiological pumps.”

Read it all.

Headline
‘Prisons should get virus jab first’

POA and nurses’ leader among the loudest calls for vaccines to be available as a priority for prisoners and staff

Read more:https://t.co/VnlaAFeHdY

— InsideTime (@InsideTimeUK) November 23, 2020

A group in France, led by veterinary scientist Dominique Grandjean at the National Veterinary School of Alfort near Paris, posted its work3 on the preprint server bioRxiv in June. The researchers, who included Sarkis, trained 8 dogs to detect COVID-19 in 198 sweat samples, around half of which were from people with the disease. When these were hidden in a row of negative samples, the dogs identified the positive samples 83–100% of the time. The paper does not say how well the dogs identified negative test results. The research is now under review at a journal, but Grandjean says the process has not been easy. “To publish papers on detection dogs is very difficult because most reviewers do not know anything about working dogs,” he says.

The data in that study look promising, says Fyodor Urnov, a gene-editing scientist who is working on COVID testing at the University of California, Berkeley. But he would like to see larger data sets on how well dogs identify positive and negative samples. He also notes that there is variation in how well individual dogs perform. In Grandjean’s study, for example, 2 dogs identified 68 out of 68 positive samples, whereas one missed 10 out of 57 cases.

Groups need to boost their sample sizes before the wider scientific community can evaluate how useful the dogs might be, agrees James Logan, an infectious-disease researcher at the London School of Hygiene & Tropical Medicine who is training and studying COVID-19 dogs, including Storm, Maple and Asher. “It’s important not to go out too early with grand claims and small data sets,” he says.

Read it all.

Can dogs smell COVID? Here’s what the science says

Canines seem to detect coronavirus infections with remarkable accuracy, but researchers say large-scale studies are needed before the approach is scaled up.https://t.co/0XgMmjdzRf pic.twitter.com/td34nAxJKW

— Rahim Azizian (@AzizianRahim) November 23, 2020

The call was tense, the message discouraging. Moncef Slaoui, the head of the Trump administration’s effort to quickly produce a vaccine for the coronavirus, was on the phone at 6 p.m. on Aug. 25 to tell the upstart biotech firm Moderna that it had to slow the final stage of testing its vaccine in humans.

Moderna’s chief executive, Stéphane Bancel, a French biochemical engineer, recognized the implication. In the race to quell the pandemic, he said, “every day mattered.” Now his company, which had yet to bring a single product to market, faced a delay of up to three weeks. Pfizer, the global pharmaceutical giant that was busy testing a similar vaccine candidate and promising initial results by October, would take the obvious lead.

“It was the hardest decision I made this year,” Mr. Bancel said.

Read it all.

Your Sunday must-read is this thriller about the US government, a multinational, and start-up racing to make a COVID-19 vaccine.

It totally shot adrenaline and pride into my American veins and is a crazy-exciting read https://t.co/Ek5JxO3vNe

— Morgan Lee (@Mepaynl) November 22, 2020

Religious leaders in Europe and the U.S. are pushing back harder against coronavirus restrictions than during the pandemic’s first wave, invoking their right to religious freedom and arguing churches are safe.

Protests in France and Britain, where bans on communal worship are now in place, have brought governments to the negotiating table with religious leaders. The Catholic diocese of Brooklyn, one of the largest in the U.S., is appealing to the U.S. Supreme Court against numerical limits on worshipers.

Church leaders were largely deferential during the spring lockdowns to curb the spread of Covid-19. Many are taking a different tack now, convinced churches shouldn’t be treated more strictly than secular activities.

“We have demonstrated, by our action, that places of worship and public worship can be made safe from Covid transmission,” wrote a group of British faith leaders to Prime Minister Boris Johnson earlier this month.

Read it all.

Religious leaders in Europe and the U.S. are pushing back against anti-coronavirus restrictions invoking their right to religious freedom https://t.co/4z2wuuL0bh

— The Wall Street Journal (@WSJ) November 20, 2020

The latest coronavirus problem in sports isn’t that far from the problem that a lot of Americans have: How can you tell if that’s a cold, or Covid? Is that sniffle allergies, or a sign of a deadly pathogen? Is that headache just a headache, or…?

One of the things that makes coronavirus a wily foe for epidemiologists is that it has a really long list of possible symptoms—including none at all.

Read it all.

Your nose is runny, you're tired, your head hurts.

It's a problem facing both NFL teams and everyday Americans deciding if they should go to work or send a child to school. Is it a cold? Flu? Allergies? Or Covid? With @louiseradnofsky: https://t.co/CSGc8TCpIc

— Andrew Beaton (@andrewlbeaton) November 20, 2020

We weren’t set up well to deal with this virus in Missouri. We have the worst funding in the country for public health, and a lot of the things we’ve needed to fight the spread of covid are things we should have had in place 10 years ago. We don’t have an emergency manager. We don’t have anyone to handle HR, public information, or IT, so that’s all been me. We didn’t get extra funding for covid until last month. I’m young and I’m motivated, and I took this job in January because public health is my absolute love. It doesn’t pay well, but would I rather be treating people who already have a disease or helping to prevent it? That’s what we do. We help take care of people. At one point this summer, I worked 90 days straight trying to hold this virus at bay, and my whole staff was basically like that.

We hired 10 contact tracers to track the spread, starting in August, but the real problem we keep running into is community cooperation. We call everyone that’s had a positive test and say: “Hey, this is your local health department. We’re trying to interrupt disease transmission, and we’d love your help.” It’s nothing new. We do the same thing for measles, mumps, and tick-borne diseases, and I’d say 99 percent of the time before covid, people were receptive. They wanted to stop an outbreak, but now it’s all politicized. Every time you get on the phone, you’re hoping you don’t get cussed at. Probably half of the people we call are skeptical or combative. They refuse to talk. They deny their own positive test results. They hang up. They say they’re going to hire a lawyer. They give you fake people they’ve spent time with and fake numbers. They lie and tell you they’re quarantining alone at home, but then in the background you can hear the beeping of a scanner at Walmart.

I’ve stayed up a lot of nights trying to understand where this whole disconnect comes from. I love living in this county. I know in my heart these are good people, but it’s like we’re living on different planets. I have people in my own family who believe covid is a conspiracy and our doctors are getting paid off. I’ve done press conferences and dozens of Facebook Live videos to talk about the real science. Even with all the other failures happening, that’s the one thing we should be celebrating: better treatments, nurses and doctors on the front lines, promising news about vaccines. But the more I talk about the facts, the more it seems to put a target on my back.

Read it all.

“I do have an agenda. I want disease transmission to go down. I want to keep this community safe. I want fewer people to die. Why is that controversial?” https://t.co/nbEhwgEK4P

— Colby Itkowitz (@ColbyItkowitz) November 18, 2020

The promising news that not just one but two coronavirus vaccines were more than 90 percent effective in early results has buoyed hopes that an end to the pandemic is in sight.

But even if the vaccines are authorized soon by federal regulators — the companies developing them have said they expect to apply soon — only a sliver of the American public will be able to get one by the end of the year. The two companies, Pfizer and Moderna, have estimated they will have 45 million doses, or enough to vaccinate 22.5 million Americans, by January.

Industry analysts and company executives are optimistic that hundreds of millions of doses will be made by next spring. But the companies — backed with billions of dollars in federal money — will have to overcome hurdles they’ve encountered in the early days of making vaccines. Moderna’s and Pfizer’s vaccines use new technology that has never been approved for widespread use. They are ramping up into the millions for the first time. Other challenges include promptly securing raw vaccine ingredients and mastering the art of creating consistent, high-quality batches.

“The biology of scaling manufacturing is a very temperamental activity, and there were many, many different attempts over the months until we cracked it,” said Paul Mango, deputy chief of staff for policy at the Department of Health and Human Services.

Read it all.

The federal government once set a goal of 300 million vaccine doses by the end of the year. But the tricky nature of manufacturing vaccines means they are nowhere near that goal. https://t.co/QH5fvoqJsj

— NYT Business (@nytimesbusiness) November 18, 2020

Looking for toilet paper? Good luck.

A surge of new coronavirus cases in the U.S. is sending people back to stores to stockpile again, leaving shelves bare and forcing retailers to put limits on purchases.

Walmart said Tuesday it’s having trouble keeping up with demand for cleaning supplies in some stores. Supermarket chains Kroger and Publix are limiting how much toilet paper and paper towels shoppers can buy after demand spiked recently. And Amazon is sold out of most disinfectant wipes and paper towels.

A similar scene played out back in March, when the pandemic first hit and people hunkered down in their homes.

Read it all.

A surge of new coronavirus cases in the U.S. is sending people back to stores to stockpile again, leaving shelves bare and forcing retailers to put limits on purchases.https://t.co/bT7j3AAPrp

— WCBD News 2 (@WCBD) November 18, 2020

Western nations face a big challenge in fighting the Covid-19 pandemic: Ten months into the health crisis, they still know little about where people are catching the virus.
The problem is becoming more acute as new cases are breaking records in the U.S. and Europe and pressure grows on authorities to impose targeted restrictions on places that are spreading the virus, rather than broad confinement measures that are wreaking havoc on the economy.

In Germany, authorities say they don’t know where 75% of people who currently test positive for the coronavirus got it. In Austria, the figure stands at 77%. In Spain, the health ministry said that it was able to identify the origin of only 7% of infections registered in the last week of October. In France and Italy, only some 20% of new cases have been linked to people who previously tested positive.

Jay Varma, senior adviser for public health in the New York City mayor’s office, said 10% of the city’s infections are due to travel, 5% from gatherings, and another 5% from institutional settings such as nursing homes.

“The vast majority of the remainder—somewhere probably around 50% or more—we don’t have a way to directly attribute their source of infection,” Mr. Varma said. “And that’s a concern.”

Read it all.

Western nations face a big challenge in fighting the Covid-19 pandemic: Ten months into the health crisis, they still know little about where people are catching the virus https://t.co/FBQyXUnYjd

— The Wall Street Journal (@WSJ) November 16, 2020

How long might immunity to the coronavirus last? Years, maybe even decades, according to a new study — the most hopeful answer yet to a question that has shadowed plans for widespread vaccination.

Eight months after infection, most people who have recovered still have enough immune cells to fend off the virus and prevent illness, the new data show. A slow rate of decline in the short term suggests, happily, that these cells may persist in the body for a very, very long time to come.

The research, published online, has not been peer-reviewed nor published in a scientific journal. But it is the most comprehensive and long-ranging study of immune memory to the coronavirus to date.

“That amount of memory would likely prevent the vast majority of people from getting hospitalized disease, severe disease, for many years,” said Shane Crotty, a virologist at the La Jolla Institute of Immunology who co-led the new study.

Read it all.

People who have recovered from the coronavirus may have immunity that lasts years, maybe even decades, according to a new study — the most hopeful answer yet to a question that has shadowed plans for widespread vaccination. https://t.co/9k6uPS3vfo

— The New York Times (@nytimes) November 17, 2020

Make sure to listen all the way to the end, where Steve talks about his experience of having Covid19 and recovering from it and what it taught him theologically.

With a third surge of the Covid-19 pandemic hitting the U.S., many public-health authorities are warning the coronavirus is now so widespread that it will take pervasive new measures to contain it.

New infections surpassed 177,224 on Friday, setting a daily record that eclipsed the highest daily case counts of previous peaks in the spring and summer. The number of new infections was lower Saturday at 166,555, while new deaths numbered nearly 1,300, according to data compiled by Johns Hopkins University. The number of people hospitalized with Covid-19, meanwhile, reached 69,455 on Saturday, according to the Covid Tracking Project.

In earlier surges, infections were concentrated in cities such as New York and Chicago, or populous states like Florida and Texas. Many of the outbreaks then were linked to travelers returning from overseas or so-called superspreading events such as conferences, weddings and rallies.

Now, it is everywhere. People are becoming infected not just at big gatherings, but when they let their guard down, such as by not wearing a mask, while going about their daily routines or in smaller social settings that they thought of as safe—often among their own families or trusted friends.

Read it all.

In the third Covid surge, people are becoming infected not just at big gatherings but during daily routines or in smaller social settings they thought of as safe. https://t.co/5IGEZdkNeG via @WSJ

— David Luhnow (@davidluhnow) November 15, 2020

With a COVID-19 vaccine drawing closer, public health officials across the country are gearing up for the biggest vaccination effort in U.S. history — a monumental undertaking that must distribute hundreds of millions of doses, prioritize who’s first in line and ensure that people who get the initial shot return for the necessary second one.

The push could begin as early as next month, when federal officials say the first vaccine may be authorized for emergency use and immediately deployed to high-risk groups, such as health care workers.

“The cavalry is coming,” Dr. Anthony Fauci said Thursday on ABC’s “Good Morning America.” He said he hopes shots will be available to all Americans in April, May and June.

Read it all.

With a COVID-19 vaccine drawing closer, public health officials across the country are gearing up for the biggest vaccination effort in U.S. history. It will be an undertaking to distribute hundreds of millions of doses and determine who’s first in line. https://t.co/pPXGiRtJqc

— The Associated Press (@AP) November 12, 2020

Results from a new Cleveland Clinic-led study suggest that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as an over-the-counter sleep aid, may be a viable treatment option for COVID-19.

As COVID-19 continues to spread throughout the world, particularly with cases rising during what some have termed the “fall surge,” repurposing drugs already approved by the U.S. Food and Drug Administration for new therapeutic purposes continues to be the most efficient and cost-effective approach to treat or prevent the disease.

According to the findings published today in PLOS Biology, a novel artificial intelligence platform developed by Lerner Research Institute researchers to identify possible drugs for COVID-19 repurposing has revealed melatonin as a promising candidate.

Analysis of patient data from Cleveland Clinic’s COVID-19 registry also revealed that melatonin usage was associated with a nearly 30 percent reduced likelihood of testing positive for SARS-CoV-2 (the virus that causes COVID-19) after adjusting for age, race, smoking history and various disease comorbidities. Notably, the reduced likelihood of testing positive for the virus increased from 30 to 52 percent for African Americans when adjusted for the same variables.

Read it all.

Lerner Research Institute News – Cleveland Clinic Researchers Use “Big Data” Approach to Identify Melatonin as Possible COVID-19 Treatment https://t.co/dljLfmHJEg via @CCLRI

— Feixiong Cheng (@FeixiongCheng) November 10, 2020

Vaccines work by stimulating a person’s immune system. One traditional approach is to inject a weakened version of the dangerous virus. That’s the way we now fend off measles, mumps, rubella and chickenpox. Another method is to use a version of the virus or a part of the virus that has been totally killed.

The success of the Pfizer vaccine means that the plague year of 2020 will be remembered as the time when traditional vaccines began to be supplanted by genetic vaccines. Instead of delivering tiny and safe doses of the virus itself, these new vaccines deliver a piece of genetic coding that will instruct human cells to produce, on their own, components of a targeted virus. These safe components can then stimulate the patient’s immune system.

It is another wondrous miracle from a biotech revolution in which knowledge of genetic coding will become as important as digital coding and molecules will become the new microchips.

Read it all.

“It is another wondrous miracle from a biotech revolution in which knowledge of genetic coding .. as important as digital coding & molecules will become the new microchips.” ⁦@washingtonpost⁩ ⁦@pfizer⁩ #COVID19 #Vaccine ⁦@BioNTech_Group⁩ https://t.co/AcBu40iSPS

— Christina Ayiotis (@christinayiotis) November 10, 2020

Pfizer and partner BioNTech said Monday that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relief — in the face of the global pandemic.

The vaccine is the first to be tested in the United States to generate late-stage data. The companies said an early analysis of the results showed that individuals who received two injections of the vaccine three weeks apart experienced more than 90% fewer cases of symptomatic Covid-19 than those who received a placebo. For months, researchers have cautioned that a vaccine that might only be 60% or 70% effective.

The Phase 3 study is ongoing and additional data could affect results….

Read it all.

BREAKING: Covid-19 vaccine from Pfizer and BioNTech is strongly effective, early data from large trial indicate https://t.co/mPdGZj8OpE

— STAT (@statnews) November 9, 2020

The Archbishops of Canterbury and York, together with the Bishop of London, have joined national faith leaders in calling on the Government to permit public worship during the forthcoming lockdown in England.

Read it all and the full letter at the link.

News: @JustinWelby @CottrellStephen & @bishopSarahM have joined with national faith leaders in calling on the Prime Minister to permit public worship during the lockdown in England. https://t.co/TbeyhkKttb

— Church of England in Parliament (@churchstate) November 3, 2020

We are grateful for people’s energy, hard work and creativity in making this happen and we hope and pray this will continue. We are grateful that the new guidelines being introduced on Thursday not only allow churches to remain open for private prayer but also enable online worship to be broadcast from the church building. We were cautious about these issues during the first lockdown – perhaps overly so – but in this second lockdown we want to encourage church buildings to remain open for private prayer wherever possible, making sure that their buildings are Covid secure in the ways that we have learned in recent months, and to broadcast services from their church buildings. However, if you do not have the resources or wherewithal to do this, please do not feel that you have failed in any way. The good thing about provision of worship online, is that people can join in from anywhere and therefore we can support each other more easily in this endeavour. Our national digital team will continue to offer training and support and provide national services each week.

However, worship online still means that the people of God do not have access to the sacraments which are so central to our life in Christ. This is a huge loss and since we were not consulted about the lockdown provisions, we fully intend to speak with government about why certain exemptions are made and not others, emphasising the critical role that churches play in every community. The sacramental life of the church cannot be seen as an optional extra. Nor can we separate out our worship from our service, it is always both and not either or.

Nevertheless, we will of course abide by the law and ask you to do the same. We must do all that we can to keep our communities safe and to enable the NHS to manage this crisis. The Recovery Group chaired by the Bishop of London will be issuing specific guidance in the next day or two.

Bearing in mind our primary vocation as the Church of Jesus Christ to pray and to serve we call upon the Church of England to make this month of lockdown a month of prayer. More than anything else, whatever the nation thinks, we know that we are in the faithful hands of the risen Christ who knows our weaknesses, tiredness and struggles and whose steadfast love endures for ever.

Read it all.

'The sacramental life of the church cannot be seen as an optional extra' I will make this clear as I speak with Government Ministers today. https://t.co/RvO3Tu98Vm

— BishopSarah (@bishopSarahM) November 2, 2020

Colleagues quietly scoffed when Alessandra Devoto, a plant biologist, started dedicating her time to researching the medicinal properties of a roadside weed. After years of study, however, she appears to have proved them wrong.

Scientists have found that Arabidopsis thaliana, also known as mouse-ear cress or thale cress, stops the growth of breast cancer without damaging the healthy cells. It could help the development of chemotherapy treatments without side-effects.

“The plant is very much like the Cinderella of the medicinal plant world — no one thought it was so special, but it has shown its true colours,” Professor Devoto, from Royal Holloway, University of London, said. “Everyone knows someone who has gone through chemotherapy and the severe side-effects it causes. This skinny little weed is a bit of a superhero, it stops the cancer cells but causes no other damage.”

It is about 20cm high and belongs to the cabbage family, though bears little resemblance.

Read it all.

Plant biologist Alessandra Devoto and a group of scientists have found that thale cress stops the growth of breast cancer without damaging the healthy cells. It could help the development of chemotherapy treatments without side-effects https://t.co/SRYt1v6uzB

— The Times (@thetimes) October 30, 2020

Asymptomatic people who are infected with Covid-19 exhibit, by definition, no discernible physical symptoms of the disease. They are thus less likely to seek out testing for the virus, and could unknowingly spread the infection to others.

But it seems those who are asymptomatic may not be entirely free of changes wrought by the virus. MIT researchers have now found that people who are asymptomatic may differ from healthy individuals in the way that they cough. These differences are not decipherable to the human ear. But it turns out that they can be picked up by artificial intelligence.

In a paper published recently in the IEEE Journal of Engineering in Medicine and Biology, the team reports on an AI model that distinguishes asymptomatic people from healthy individuals through forced-cough recordings, which people voluntarily submitted through web browsers and devices such as cellphones and laptops.

The researchers trained the model on tens of thousands of samples of coughs, as well as spoken words. When they fed the model new cough recordings, it accurately identified 98.5 percent of coughs from people who were confirmed to have Covid-19, including 100 percent of coughs from asymptomatics — who reported they did not have symptoms but had tested positive for the virus.

Read it all.

"A user could log in daily, cough into their phone, and instantly get information on whether they might be infected & therefore should confirm with a formal test."https://t.co/IUfYDtNZ4E#COVID19 #CovidCollab #coronavirus #SARSCoV2 #AI #ML #MedTwitter #HealthTech #crowdsource

— Polyplexus.com (@polyplexors) October 29, 2020

South Carolina health officials reported another 755 new cases of COVID-19 on Tuesday, as the state’s rate of cases continues to rise over the past month.

Tuesday’s case count marks the fifth time in the last six days officials from the Department of Health and Environmental Control have reported more than 750 new cases of the novel coronavirus, and the state’s seven-day rolling average of new cases is now just under 1,000, a mark it hasn’t passed since early September.

State health officials also recorded 19 more confirmed deaths related to the virus Tuesday. Since the first cases were identified in South Carolina in March, officials have reported 164,802 cases and 3,602 deaths.

Read it all.

The rate of new cases and percentage of positive tests have increased over the past 30 days, DHEC reports. https://t.co/5E5HdR9gsn

— The State Newspaper (@thestate) October 27, 2020

The experimental COVID-19 vaccine codeveloped by the U.S.’s Pfizer, Germany’s BioNTech, and China’s Fosun Pharmaceuticals may reach market as early as this December, according to the chairman of Fosun Group.

“Once the vaccine is proved to be safe and effective [after trial results are posted in November], the vaccine will be made available in the market by December [2020] or January next year,” Guo Guangchang, chair of the parent company of Fosun Pharmaceuticals, said Tuesday at the Fortune Global Forum.

Read it all.

Chinese partner says Pfizer COVID vaccine may reach market by December https://t.co/XHkav6eJXf pic.twitter.com/faAMwRD5Wh

— WBMN Groovin' 24/7 (@RadioBlackOn) October 27, 2020

A vaccine considered a frontrunner in the race to protect the global population from Covid-19 has produced a robust immune response in elderly people, the group at highest risk from the disease, according to two people familiar with the finding.

The discovery that the vaccine being developed by the University of Oxford, in collaboration with AstraZeneca, triggers protective antibodies and T-cells in older age groups has encouraged researchers as they seek evidence that it will spare those in later life from serious illness or death from the virus.

Age has emerged as the principal risk factor for a severe bout of Covid-19. However, the immune system weakens with age, raising concerns that the very group that most needs the protection of a vaccine may generate the least effective response to one.

Read it all.

Oxford Covid vaccine trials offer hope for the elderly https://t.co/YfbxIL0jyu

— Financial Times (@FT) October 26, 2020

The S.C. Department of Health and Environmental Control is seeking a new leader to fight the coronavirus pandemic as the unprecedented health crisis marches through the state — and some officials say it’s critical that DHEC choose the right person.

It may be late December before the agency makes a decision on a new executive director to replace Rick Toomey, who resigned in late spring during the height of the pandemic. Toomey, who had high blood pressure and a heart condition, served less than 18 months.

So far, the board has received 45 applications for the director’s job, which pays a minimum of $178,126 annually. Acting director Marshall Taylor, the department’s chief legal counsel, has not applied for the position, a spokeswoman said.

The agency’s board is scheduled to meet Monday to discuss the vacancy.

“The board is committed to ensuring the most appropriate, qualified, and experienced individuals are reviewed for this important position,’’ agency spokeswoman Cristi Moore said in an email.

Read it all.

State agency seeks leader as coronavirus rages in South Carolina https://t.co/VbvDlzGloZ

— The State Newspaper (@thestate) October 24, 2020

My dentist was becoming a Shrewd Samaritan. But how is a Shrewd Samaritan different from others with good intentions toward the needy?

If we want to genuinely help people living in poverty—and a world in the middle of a global pandemic—rather than just feeling good about believing we have helped, we are not merely to be Good Samaritans, like the man commended in the famous parable in Luke 10. We should also be Shrewd Samaritans—shrewd like the manager in the less-famous parable in Luke 16, whom Jesus also points to as an example.

In the original Greek, the word for the manager in the parable is oikonómon, which literally means “Econo-Man.” We must be people with big hearts like the Good Samaritan but with minds like the Econo-Man. This means learning to love our global neighbors wisely, one might say even “shrewdly,” by making the best use of our resources—our time, talents, and money—on behalf of those who are victims of injustice, disease, violence, and poverty.

Shrewd Samaritans have made progress through what I call the seven I’s. They have moved past ignorance, indifference, and idealism and toward investigation, introspection, and impact. They have even come to identify with those they seek to serve.

Shrewd Samaritans understand the underlying causes of poverty and need. They can identify interventions that are likely to be effective in different contexts. Their motivation is fueled by the Christian call to love our neighbors, but their means are influenced by an understanding of cause and effect and even by good science. Shrewd Samaritans are wedded to a biblical view of humanity and informed by a desire for human flourishing in all respects: physical, psychological, social, and spiritual.

Read it all.

Our COVID-19 response to those in need can't just be well-intentioned.

It must be shrewd.

How we can love our local & global neighbors most effectively, from developmental economist @BruceWydick and disaster-relief expert @kentannan: https://t.co/VkUN3DYjX5

— Christianity Today (@CTmagazine) October 23, 2020

Key insights from an ongoing Church of England research programme into clergy flourishing are to be distributed to curates across the country as part of an initiative to promote clergy wellbeing, it was announced…[this week].

Findings from the first phase of the Living Ministry project – a 10-year study into clergy flourishing and wellbeing – have been incorporated into a new booklet, How Clergy Thrive, published by Church House Publishing.

The booklet, sponsored by Clergy Support Trust, is a practical resource for all clergy. It summaries qualitative and quantitative findings from the research in areas including the spiritual, relational, physical and mental as well as material wellbeing of clergy and ordinands.

The study identifies six principles that contribute to the wellbeing of ordained ministers, including handling expectations, recognising times of vulnerability, healthy boundaries and the importance of affirmation.

Read it all.

We're committed to improving the wellbeing of all. 🙏

From an initiative to promote clergy wellbeing, insights from research into clergy flourishing are being distributed to curates across England.

Discover How Clergy Thrive at the link below.https://t.co/6qm3N7kbkt

— The Church of England (@churchofengland) October 21, 2020

The University of South Carolina decided to cancel an annual college rite, spring break, to avoid a potential COVID-19 outbreak from thousands of students returning to campus after traveling.

The week of days off usually scheduled in March will be sprinkled throughout the spring semester, the state’s largest college announced in an email to parents and students Thursday. USC is calling the days off “wellness days” scheduled for: Thursday, Feb. 25; Friday, March 12; Tuesday, March 30; and Wednesday, April 21.

“I certainly understand your disappointment with this announcement,” USC Provost Bill Tate said in an email sent to university community. “However, I, and the medical community, firmly believe it is the right thing to do in light of the unprecedented worldwide pandemic.”

College of Charleston, South Carolina’s third-largest school, canceled spring break as well. Clemson University, second only to USC in enrollment in the state, has not announced a decision.

Read it all.

NEW: @UofSC cancels spring break to avoid #COVID19 outbreak https://t.co/FCYqV9eUFi

— Post and Courier Columbia (@PCColumbia) October 22, 2020